Evidence map›Paper›PMID 39836532›Full record

ArticleJournal of cosmetic dermatology2025

Tea (Camellia sinensis) Seed Saponins Act as Sebosuppression Agents via the AMPK/mTOR Pathway.

Jian Li, Yuan-Cheng Huang, Jian-Ming Deng, Min Yu, Christos C Zouboulis, Guang-Li Wang, Jing Wang

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Molecules (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Saponin from Tea (Molecules (Basel, Switzerland) · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jian LiCosmetic Research Center, School of Chemical and Material Engineering, Jiangnan University, Wuxi, China.
Yuan-Cheng HuangGuangzhou Huashi Cosmetic Technology Co. Ltd., Guangzhou, Guangdong, China.
Jian-Ming DengGuangzhou Huashi Cosmetic Technology Co. Ltd., Guangzhou, Guangdong, China.
Min YuGuangzhou Huashi Cosmetic Technology Co. Ltd., Guangzhou, Guangdong, China.
Christos C ZouboulisDepartment of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodore Fontane and Faculty of Health Sciences, Dessau, Germany.
Guang-Li WangCosmetic Research Center, School of Chemical and Material Engineering, Jiangnan University, Wuxi, China.ORCID https://orcid.org/0000-0002-6662-839X
Jing WangCosmetic Research Center, School of Chemical and Material Engineering, Jiangnan University, Wuxi, China.

Funding

Guangzhou Huashi Cosmetic Technology Co. Ltd.
6 · The paper itself

Abstract

backgroundExcessive lipogenesis of the skin triggers some dermatological concerns, such as enlarged pores, acne, and blackheads. Although topical drug treatments can offer temporary relief, their prolonged usage may lead to side effects of dryness, irritation, or allergic reactions. Consequently, the development of safer and efficacious ingredients in cosmetics for managing sebum overproduction represents a significant yet challenging endeavor.

aimSaponins were extracted from tea (Camellia sinensis) seed meal and purified by macroporous resin in order to investigate the impact of tea seed saponins (TSS) on lipid production in human immortalized sebaceous cells. Moreover, we attempted to reveal the underlying mechanism of TSS on the sebosuppression effect in SZ95 sebocytes stimulated by linoleic acid (LA).

methodsThe compositions and chemical structures of TSS were determined using UV-vis absorption spectrum, Fourier transform-infrared (FTIR) spectrum, and ultra-high-performance liquid chromatography-mass spectrometry analysis. An in vitro model of cellular lipid accumulation induced by LA was established. Total lipid synthesis in intracellular SZ95 sebocytes was assessed through Nile Red staining, while triglyceride, cholesterol, and fatty acids were quantified by commercially assay kits. Western blot and quantitative real-time polymerase chain reaction were employed to analyze the protein expression levels involved in the AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway as well as the downstream protein and mRNA expressions of sterol regulatory element-binding protein-1 (SREBP-1), peroxisome proliferator-activated receptor γ (PPARγ), and fatty acid synthase (FAS). The localizations of SREBP-1 within the cytoplasm or nucleus were characterized using immunofluorescence staining.

resultsFive saponins were identified in the extracted TSS, all of which were oleanic acid-type pentacyclic triterpenes. TSS treatment significantly alleviated LA-induced lipid accumulation in SZ95 sebocytes. In addition, TSS activated the AMPK/mTOR pathway and downregulated the downstream protein and mRNA expression of transcription factors and enzymes, including SREBP-1, PPARγ, and FAS. Moreover, the TSS blocked the nuclear transfer of SREBP-1 from cytoplasm to nucleus.

conclusionIn human sebocytes, TSS exhibited sebosuppressive effect as revealed by the inhibited production of total lipids as well as triglyceride, cholesterol, and fatty acids. Moreover, the anti-lipogenesis mechanism by TSS involved the activation of the AMPK/mTOR pathway and downregulated downstream transcription factors and enzymes of SREBP-1, PPARγ, and FAS. Additionally, TSS blocked the SREBP-1 nuclear translocation. These results may justify the potent of TSS as a new candidate for modulating lipogenesis in human SZ95 sebocytes.

Indexed as

Camellia sinensisLipogenesisSaponinsSebaceous GlandsAMP-Activated Protein KinasesCell LineHumansLinoleic AcidSeedsSignal TransductionSterol Regulatory Element Binding Protein 1TOR Serine-Threonine KinasesAMP-Activated Protein KinasesLinoleic AcidMTOR protein, humanSaponinsSterol Regulatory Element Binding Protein 1TOR Serine-Threonine KinasesAMPK/mTORhuman sebocyteslipid synthesistea seed saponins

Identifiers

PMID39836532
PMCPMC11750075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.